ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Carbonate → 3-[[3-(2-Fluoro-pyridin-4-ylmethyl)-5-isopropyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl]-(4-methoxy-benzyloxyimino)-methyl]-5-methyl-benzonitrile

HRID 426257
印刷

反応式

HRID 426257 の反応式
[CH:1]([C:4]1[C:9](=[O:10])[NH:8][C:7](=[O:11])[NH:6][C:5]=1[C:12](=[N:22][O:23][CH2:24][C:25]1[CH:30]=[CH:29][C:28]([O:31][CH3:32])=[CH:27][CH:26]=1)[C:13]1[CH:14]=[C:15]([CH:18]=[C:19]([CH3:21])[CH:20]=1)[C:16]#[N:17])([CH3:3])[CH3:2].C(=O)([O-])[O-].[K+].[K+].Br[CH2:40][C:41]1[CH:46]=[CH:45][N:44]=[C:43]([F:47])[CH:42]=1.[I-].[Li+]>CN(C=O)C.C(OCC)(=O)C>[F:47][C:43]1[CH:42]=[C:41]([CH2:40][N:6]2[C:5]([C:12](=[N:22][O:23][CH2:24][C:25]3[CH:26]=[CH:27][C:28]([O:31][CH3:32])=[CH:29][CH:30]=3)[C:13]3[CH:14]=[C:15]([CH:18]=[C:19]([CH3:21])[CH:20]=3)[C:16]#[N:17])=[C:4]([CH:1]([CH3:3])[CH3:2])[C:9](=[O:10])[NH:8][C:7]2=[O:11])[CH:46]=[CH:45][N:44]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 11430Potassium CarbonateHCID 66321Lithium iodideHCID 139851684-Bromomethyl-2-fluoropyridineHCID 866192353-[(5-Isopropyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl)-(4-methoxybenzyloxyimino)-methyl]-5-methyl-benzonitrile

生成物 1

HCID 866192343-[[3-(2-Fluoro-pyridin-4-ylmethyl)-5-isopropyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl]-(4-methoxy-benzyloxyimino)-methyl]-5-methyl-benzonitrile

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

3-[(5-Isopropyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl)-(4-methoxybenzyloxyimino)-methyl]-5-methyl-benzonitrile (71 mg, 0.164 mmol, 1.2 eq.) was dissolved in 2.0 mL DMF. Potassium carbonate (19 mg, 0.137 mmol, 1 eq.) and 4-bromomethyl-2-fluoro-pyridine (26 mg, 1 eq.) were added to the reaction, followed by lithium iodide (18 mg, 1 eq.) The reaction was stirred at room temperature overnight. Ethyl acetate was added to the reaction mixture, followed by washing with brine. The organic layer was concentrated down and purified (silica gel, 20-80% EtOAc/hexane) to white powder (32 mg, 36%). LC-MS shows 542.2 (M+1). 1H NMR (300 MHz, CDCl3): δ 8.80 (br, 1H), 7.93 (d, 1H), 7.62 (s, 1H), 7.42 (s, 1H), 7.32 (d, 2H), 7.21 (s, 1H), 6.92 (d, 2H), 6.72 (d, 1H), 6.40 (s, 1H), 5.08 (dd, 2H), 4.90 (d, 1H), 4.22 (d, 1H), 3.80 (s, 3H), 2.32 (s, 3H), 2.20 (m, 1H), 1.16 (d, 3H), 1.12 (d, 3H).

後処理

  1. washby washing with brine
  2. concentrationThe organic layer was concentrated down
  3. custompurified (silica gel, 20-80% EtOAc/hexane) to white powder (32 mg, 36%)

出典と根拠

ORDレコード
ord-b4b0368736674c7da089d1dc3c4f05e2
出典データセット
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08106064B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート